@GladellPaner @slusagar Do you ever use AMACR for the distinction CIS vs reactive atypia or do you always stick to CK20/p53/CD44 if you have to use IHC? I've read the article below and was wondering what your experience is with this. Thank you! https://t.
RT @Gleason4plus5: Interesting paper here about utility of AMACR vs CK20 and p53 in evaluating flat bladder atypia. I rarely use these - bo…
RT @Gleason4plus5: Interesting paper here about utility of AMACR vs CK20 and p53 in evaluating flat bladder atypia. I rarely use these - bo…
Interesting paper here about utility of AMACR vs CK20 and p53 in evaluating flat bladder atypia. I rarely use these - borderline cases often best served clinically by caution - but can be useful in some cases! #gupath https://t.co/iZSTROnxqr https://t.co/k